ValueSet Comparison between http://hl7.org/fhir/us/core/ValueSet/us-core-vaccines-cvx vs http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6

Messages

Metadata

Name	Value		Comments
compose.inactive
compose.lockedDate
copyright
date	2019-05-21	2023-07-15T01:01:22-04:00	Values Differ
description	This identifies the vaccine substance administered - CVX codes. **Inclusion Criteria:** Any CVX code with CVX 'status' (VSAC Property) = `Active`,` Inactive`, `Non-US` except those noted in exclusions. **Exclusion Criteria:** CVX codes that have a CVX 'status' of either `Pending` or `Never Active` AND CVX codes with CVX 'Nonvaccine' property = True. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx		Removed the item 'This identifies the vaccine substance administered - CVX codes. **Inclusion Criteria:** Any CVX code with CVX 'status' (VSAC Property) = `Active`,` Inactive`, `Non-US` except those noted in exclusions. **Exclusion Criteria:** CVX codes that have a CVX 'status' of either `Pending` or `Never Active` AND CVX codes with CVX 'Nonvaccine' property = True. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx'
experimental
immutable
jurisdiction
jurisdiction[0]	urn:iso:std:iso:3166#US
name	USCoreVaccineAdministeredValueSetCvx	CVXVaccinesAdministeredVaccineSet	Values Differ
publisher	HL7 US Realm Steering Committee	HL7 Terminology	Values Differ
purpose		(Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.)	Added the item '(Clinical Focus: CVX vaccine concepts that represent actual vaccines types, including those that are historical record of a vaccine administered where the exact formulation is unknown. This does not include the identifiers for CVX codes that are administrative codes or never active codes. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx),(Data Element Scope: Vaccine representation),(Inclusion Criteria: Any CVX code with "CVX status" (VSAC Property) = Active, Inactive, Non-US except those noted in exclusions),(Exclusion Criteria: CVX codes that have a CVX "status" of either "Pending" or "Never Active" AND CVX codes with CVX "Nonvaccine" property = True.)'
status	active
title	US Core Vaccine Administered Value Set (CVX)	CVX Vaccines Administered Vaccine Set	Values Differ
url	http://hl7.org/fhir/us/core/ValueSet/us-core-vaccines-cvx	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6	Values Differ
version	3.1.1	20230715	Values Differ

Definition

Item	Property		Value		Comments
include	http://hl7.org/fhir/sid/cvx
Concept	01		diphtheria, tetanus toxoids and pertussis vaccine
Concept	02		trivalent poliovirus vaccine, live, oral
Concept	03		measles, mumps and rubella virus vaccine
Concept	04		measles and rubella virus vaccine
Concept	05		measles virus vaccine
Concept	06		rubella virus vaccine
Concept	07		mumps virus vaccine
Concept	08		hepatitis B vaccine, pediatric or pediatric/adolescent dosage
Concept	09		tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
Concept	10		poliovirus vaccine, inactivated
Concept	100		pneumococcal conjugate vaccine, 7 valent
Concept	101		typhoid Vi capsular polysaccharide vaccine
Concept	102		DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
Concept	103		meningococcal C conjugate vaccine
Concept	104		hepatitis A and hepatitis B vaccine
Concept	105		vaccinia (smallpox) vaccine, diluted
Concept	106		diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
Concept	107		diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
Concept	108		meningococcal ACWY vaccine, unspecified formulation
Concept	109		pneumococcal vaccine, unspecified formulation
Concept	11		pertussis vaccine
Concept	110		DTaP-hepatitis B and poliovirus vaccine
Concept	111		influenza virus vaccine, live, attenuated, for intranasal use
Concept	112		tetanus toxoid, unspecified formulation
Concept	113		tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
Concept	114		meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
Concept	115		tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
Concept	116		rotavirus, live, pentavalent vaccine
Concept	117		Version: varicella zoster immune globulin (Investigational New Drug)		Removed this Concept
Concept	118		human papilloma virus vaccine, bivalent
Concept	119		rotavirus, live, monovalent vaccine
Concept	12		Version: diphtheria antitoxin		Removed this Concept
Concept	120		diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
Concept	121		zoster vaccine, live
Concept	122		rotavirus vaccine, unspecified formulation
Concept	123		influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
Concept	125		Novel Influenza-H1N1-09, live virus for nasal administration
Concept	126		Novel influenza-H1N1-09, preservative-free, injectable
Concept	127		Novel influenza-H1N1-09, injectable
Concept	128		Novel influenza-H1N1-09, all formulations
Concept	129		Japanese Encephalitis vaccine, unspecified formulation
Concept	13		Version: tetanus immune globulin		Removed this Concept
Concept	130		Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
Concept	131		Historical record of a typhus vaccination
Concept	132		Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
Concept	133		pneumococcal conjugate vaccine, 13 valent
Concept	134		Japanese Encephalitis vaccine for intramuscular administration
Concept	135		influenza, high dose seasonal, preservative-free
Concept	136		meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
Concept	137		HPV, unspecified formulation
Concept	138		tetanus and diphtheria toxoids, not adsorbed, for adult use
Concept	139		Td(adult) unspecified formulation
Concept	14		Version: immune globulin, unspecified formulation		Removed this Concept
Concept	140		Influenza, seasonal, injectable, preservative free
Concept	141		Influenza, seasonal, injectable
Concept	142		tetanus toxoid, not adsorbed
Concept	143		Adenovirus, type 4 and type 7, live, oral
Concept	144		seasonal influenza, intradermal, preservative free
Concept	147		Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
Concept	148		Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Concept	149		influenza, live, intranasal, quadrivalent
Concept	15		influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
Concept	150		Influenza, injectable, quadrivalent, preservative free
Concept	151		influenza nasal, unspecified formulation
Concept	152		Pneumococcal Conjugate, unspecified formulation
Concept	153		Influenza, injectable, Madin Darby Canine Kidney, preservative free
Concept	155		Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free
Concept	156		Version: Rho(D) Immune globulin- IV or IM		Removed this Concept
Concept	157		Version: Rho(D) Immune globulin - IM		Removed this Concept
Concept	158		influenza, injectable, quadrivalent, contains preservative
Concept	159		Version: Rho(D) Unspecified formulation		Removed this Concept
Concept	16		influenza virus vaccine, whole virus
Concept	160		Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
Concept	161		Influenza, injectable,quadrivalent, preservative free, pediatric
Concept	162		meningococcal B vaccine, fully recombinant
Concept	163		meningococcal B vaccine, recombinant, OMV, adjuvanted
Concept	164		meningococcal B, unspecified formulation
Concept	165		Human Papillomavirus 9-valent vaccine
Concept	166		influenza, intradermal, quadrivalent, preservative free, injectable
Concept	167		meningococcal vaccine of unknown formulation and unknown serogroups
Concept	168		Seasonal trivalent influenza vaccine, adjuvanted, preservative free
Concept	169		Hep A, live attenuated-IM
Concept	17		Haemophilus influenzae type b vaccine, conjugate unspecified formulation
Concept	170		non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
Concept	171		Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent
Concept	172		cholera, WC-rBS
Concept	173		cholera, BivWC
Concept	174		cholera, live attenuated
Concept	175		Human Rabies vaccine from human diploid cell culture
Concept	176		Human rabies vaccine from Chicken fibroblast culture
Concept	177		pneumococcal conjugate vaccine, 10 valent
Concept	178		Non-US bivalent oral polio vaccine (types 1 and 3)
Concept	179		Non-US monovalent oral polio vaccine, unspecified formulation
Concept	18		rabies vaccine, for intramuscular injection RETIRED CODE
Concept	180		Version: tetanus immune globulin		Removed this Concept
Concept	181		Version: anthrax immune globulin		Removed this Concept
Concept	182		Oral Polio Vaccine, Unspecified formulation
Concept	183		Yellow fever vaccine alternative formulation
Concept	184		Yellow fever vaccine, unspecified formulation
Concept	185		Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free
Concept	186		Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative
Concept	187		zoster vaccine recombinant
Concept	188		zoster vaccine, unspecified formulation
Concept	189		Hepatitis B vaccine (recombinant), CpG adjuvanted
Concept	19		Bacillus Calmette-Guerin vaccine
Concept	20		diphtheria, tetanus toxoids and acellular pertussis vaccine
Concept	21		varicella virus vaccine
Concept	22		DTP-Haemophilus influenzae type b conjugate vaccine
Concept	23		plague vaccine
Concept	24		anthrax vaccine
Concept	25		typhoid vaccine, live, oral
Concept	26		cholera vaccine, unspecified formulation
Concept	27		Version: botulinum antitoxin		Removed this Concept
Concept	28		diphtheria and tetanus toxoids, adsorbed for pediatric use
Concept	29		Version: cytomegalovirus immune globulin, intravenous		Removed this Concept
Concept	30		Version: hepatitis B immune globulin		Removed this Concept
Concept	31		hepatitis A vaccine, pediatric dosage, unspecified formulation
Concept	32		meningococcal polysaccharide vaccine (MPSV4)
Concept	33		pneumococcal polysaccharide vaccine, 23 valent
Concept	34		Version: rabies immune globulin		Removed this Concept
Concept	35		tetanus toxoid, adsorbed
Concept	36		Version: varicella zoster immune globulin		Removed this Concept
Concept	37		yellow fever vaccine
Concept	38		rubella and mumps virus vaccine
Concept	39		Japanese Encephalitis Vaccine SC
Concept	40		rabies vaccine, for intradermal injection
Concept	41		typhoid vaccine, parenteral, other than acetone-killed, dried
Concept	42		hepatitis B vaccine, adolescent/high risk infant dosage
Concept	43		hepatitis B vaccine, adult dosage
Concept	44		hepatitis B vaccine, dialysis patient dosage
Concept	45		hepatitis B vaccine, unspecified formulation
Concept	46		Haemophilus influenzae type b vaccine, PRP-D conjugate
Concept	47		Haemophilus influenzae type b vaccine, HbOC conjugate
Concept	48		Haemophilus influenzae type b vaccine, PRP-T conjugate
Concept	49		Haemophilus influenzae type b vaccine, PRP-OMP conjugate
Concept	50		DTaP-Haemophilus influenzae type b conjugate vaccine
Concept	51		Haemophilus influenzae type b conjugate and Hepatitis B vaccine
Concept	52		hepatitis A vaccine, adult dosage
Concept	53		typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
Concept	54		adenovirus vaccine, type 4, live, oral
Concept	55		adenovirus vaccine, type 7, live, oral
Concept	62		human papilloma virus vaccine, quadrivalent
Concept	66		Lyme disease vaccine
Concept	69		parainfluenza-3 virus vaccine
Concept	71		Version: respiratory syncytial virus immune globulin, intravenous		Removed this Concept
Concept	74		rotavirus, live, tetravalent vaccine
Concept	75		vaccinia (smallpox) vaccine
Concept	76		Version: Staphylococcus bacteriophage lysate		Removed this Concept
Concept	77		tick-borne encephalitis vaccine	Tick-borne encephalitis vaccine (non-US)
Concept	78		tularemia vaccine
Concept	79		Version: vaccinia immune globulin		Removed this Concept
Concept	80		Venezuelan equine encephalitis, live, attenuated
Concept	801		Version: AS03 Adjuvant		Removed this Concept
Concept	81		Venezuelan equine encephalitis, inactivated
Concept	82		adenovirus vaccine, unspecified formulation
Concept	83		hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
Concept	84		hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
Concept	85		hepatitis A vaccine, unspecified formulation
Concept	86		Version: immune globulin, intramuscular		Removed this Concept
Concept	87		Version: immune globulin, intravenous		Removed this Concept
Concept	88		influenza virus vaccine, unspecified formulation
Concept	89		poliovirus vaccine, unspecified formulation
Concept	90		rabies vaccine, unspecified formulation
Concept	91		typhoid vaccine, unspecified formulation
Concept	92		Venezuelan equine encephalitis vaccine, unspecified formulation
Concept	93		Version: respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular		Removed this Concept
Concept	94		measles, mumps, rubella, and varicella virus vaccine
Concept	95		Version: tuberculin skin test; old tuberculin, multipuncture device		Removed this Concept
Concept	96		Version: tuberculin skin test; purified protein derivative solution, intradermal		Removed this Concept
Concept	97		Version: tuberculin skin test; purified protein derivative, multipuncture device		Removed this Concept
Concept	98		Version: tuberculin skin test; unspecified formulation		Removed this Concept
Concept	998		Version: no vaccine administered		Removed this Concept
Concept		146		Version: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.	Added this Concept
Concept		190		Version: Typhoid conjugate vaccine (non-US)	Added this Concept
Concept		191		Version: meningococcal A polysaccharide vaccine (non-US)	Added this Concept
Concept		192		Version: meningococcal AC polysaccharide vaccine (non-US)	Added this Concept
Concept		193		Version: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)	Added this Concept
Concept		194		Version: influenza, Southern Hemisphere, unspecified formulation	Added this Concept
Concept		195		Version: Diphtheria, Tetanus, Poliomyelitis adsorbed	Added this Concept
Concept		196		Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified	Added this Concept
Concept		197		Version: influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free	Added this Concept
Concept		198		Version: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)	Added this Concept
Concept		200		Version: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free	Added this Concept
Concept		201		Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative	Added this Concept
Concept		202		Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative	Added this Concept
Concept		203		Version: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free	Added this Concept
Concept		204		Version: Ebola Zaire vaccine, live, recombinant, 1mL dose	Added this Concept
Concept		205		Version: influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free	Added this Concept
Concept		206		Version: Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection	Added this Concept
Concept		207		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose	Added this Concept
Concept		208		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose	Added this Concept
Concept		210		Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL	Added this Concept
Concept		211		Version: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose	Added this Concept
Concept		212		Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL	Added this Concept
Concept		213		Version: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED	Added this Concept
Concept		214		Version: Ebola, unspecified	Added this Concept
Concept		215		Version: Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free	Added this Concept
Concept		216		Version: Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free	Added this Concept
Concept		217		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation	Added this Concept
Concept		218		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation	Added this Concept
Concept		219		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation	Added this Concept
Concept		220		Version: Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted	Added this Concept
Concept		221		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose	Added this Concept
Concept		222		Version: Tick-borne encephalitis vaccine, unspecified	Added this Concept
Concept		223		Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose	Added this Concept
Concept		224		Version: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose	Added this Concept
Concept		227		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose	Added this Concept
Concept		228		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose	Added this Concept
Concept		229		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose	Added this Concept
Concept		230		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose	Added this Concept
Concept		231		Version: influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free	Added this Concept
Concept		300		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation	Added this Concept
Concept		301		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation	Added this Concept
Concept		302		Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation	Added this Concept
Concept		500		Version: SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown	Added this Concept
Concept		501		Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)	Added this Concept
Concept		502		Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)	Added this Concept
Concept		503		Version: SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)	Added this Concept
Concept		504		Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)	Added this Concept
Concept		505		Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)	Added this Concept
Concept		506		Version: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology	Added this Concept
Concept		507		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)	Added this Concept
Concept		508		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)	Added this Concept
Concept		509		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)	Added this Concept
Concept		510		Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)	Added this Concept
Concept		511		Version: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)	Added this Concept
Concept		512		Version: SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)	Added this Concept
Concept		513		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)	Added this Concept
Concept		514		Version: SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)	Added this Concept
Concept		515		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)	Added this Concept
Concept		516		Version: SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)	Added this Concept
Concept		517		Version: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)	Added this Concept
Concept		518		Version: SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)	Added this Concept
Concept		519		Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna	Added this Concept
Concept		520		Version: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech	Added this Concept
Concept		521		Version: SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK	Added this Concept
Concept		56		Version: dengue fever vaccine, tetravalent	Added this Concept

Expansion

Unable to generate expansion - see errors